In children and adolescents, the pharmacodynamics of high-dose busulfan is dependent on the second alkylating agent used in the combined regimen (melphalan or thiotepa)

Author:

Bouligand J,Boland I,Valteau-Couanet D,Deroussent A,Kalifa C,Hartmann O,Vassal G

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Reference49 articles.

1. Dunn CD . The chemical and biological properties of busulphan (“Myleran”). Exp Hematol 1974; 2: 101–117.

2. Santos GW, Tutschka PJ, Brookmeyer R et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 1983; 309: 1347–1353.

3. Lenarsky C, Kohn DB, Weinberg KI, Parkman R . Bone marrow transplantation for genetic diseases. Hematol Oncol Clin North Am 1990; 4: 589–602.

4. Lenarsky C, Parkman R . Bone marrow transplantation for the treatment of immune deficiency states. Bone Marrow Transplant 1990; 6: 361–369.

5. Santos GW . The development of busulfan/cyclophosphamide preparative regimens. Semin Oncol 1993; 20: 12–16.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3